1
Isoquercetin in Sickle Cell Anemia
Condition(s):Sickle Cell Disease; Sickle Cell-Beta0-ThalassemiaLast Updated:January 11, 2021Withdrawn
Isotrifolin as an Intervention: 13 Clinical Trials, Page 1 of 2
Hide Studies Not Open or Pending
2
Study of Isoquercetin (IQC-950AN) Plus Standard of Care Versus Standard of Care Only for the Treatment of COVID-19
Condition(s):COVID-19Last Updated:August 23, 2021Not yet recruiting
3
Cancer Associated Thrombosis and Isoquercetin (CATIQ)
Condition(s):Thromboembolism of Vein VTE in Colorectal Cancer; Thromboembolism of Vein in Pancreatic Cancer; Thromboembolism of Vein in Non-small Cell Lung CancerLast Updated:March 3, 2021Completed
4
Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19
Condition(s):SARS-CoV 2; COVID-19; Coronavirus Disease 2019Last Updated:September 17, 2021Recruiting
5
Study to Investigate the Clinical Efficacy of Isoquercetin in Patients With COVID-19
Condition(s):Covid19Last Updated:February 5, 2021Not yet recruiting
6
Fixed Dose Flavonoid Isoquercetin on Thrombo-Inflammatory Biomarkers in Subjects With Stable Sickle Cell Disease
Condition(s):SCDLast Updated:June 16, 2022Active, not recruiting
7
Quercetin PK/PD Study in Healthy Adults and Patients With Hypercoagulable States
Condition(s):HealthyLast Updated:October 12, 2020Completed
8
Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-line Sunitinib: a Phase I/II Trial
Condition(s):Renal Cell Carcinoma; Kidney CancerLast Updated:January 18, 2017Unknown status
9
Impact of isoQUercetin and Aspirin on Platelet Function
Condition(s):Cardiovascular DiseaseLast Updated:November 29, 2016Withdrawn
10
Nitrite, Isoquercetin and Endothelial Dysfunction (NICE) Trial
Condition(s):Chronic Kidney DiseaseLast Updated:April 20, 2021Completed